Real-world clinical and economic outcomes for daily teriparatide patients in Japan
Crossref DOI link: https://doi.org/10.1007/s00774-015-0720-0
Published Online: 2015-12-10
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Burge, Russel
Sato, Masayo
Sugihara, Tomoko
Funding for this research was provided by:
Eli Lilly and Company
Text and Data Mining valid from 2015-12-10